NYSE · Financial Statements

Attovia Therapeutics, Inc. (ATTO) Financial Statements

$13.73 NYSE: ATTO Market Cap $626.79M

Attovia Therapeutics, Inc. most recently reported annual revenue of $1.4B, a net loss of $90.0M. Revenue declined at an average annual rate of 3.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20172018201920202021
Revenue$1.9B$1.8B$1.7B$1.4B$1.4B
Operating Profit$92.0M$90.0M$64.0M$56.0M$73.0M
Net Profit$-17.0M$19.0M$-81.0M$-47.0M$-90.0M
EPS$-1.14$1.24$-5.59$-3.32$-6.41
Op Margin4.8%4.9%3.7%4.0%5.0%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$1.3B$1.2B$1.3B$1.2B$1.1B
Total Liabilities$953.0M$873.0M$1.1B$1.1B$1.1B
Cash$142.0M$134.0M$125.0M$209.0M$129.0M
Borrowings$486.0M$460.0M$721.0M$727.0M$718.0M

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$114.0M$81.0M$46.0M$128.0M$42.0M
Investing Cash Flow$-168.0M$-81.0M$-96.0M$-76.0M$-99.0M
Financing Cash Flow$-60.0M$-40.0M$-6.0M$-2.0M$-59.0M
Net Cash Flow$-52.0M$-8.0M$-9.0M$84.0M$-80.0M
Free Cash Flow$38.0M$41.0M$6.0M$90.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.29
EV / EBITDA5.90
FCF Yield-0.96%
Quick Ratio1.24
Interest Coverage0.79
Return 1Y—
Return 3Y—
Return 5Y—

Attovia Therapeutics, Inc. (ATTO) financials — frequently asked questions

What is Attovia Therapeutics, Inc.'s annual revenue?

Attovia Therapeutics, Inc. (ATTO) reported annual revenue of $1.4B in its most recent fiscal year.

What is Attovia Therapeutics, Inc.'s net profit?

Attovia Therapeutics, Inc. (ATTO) reported a net loss of $90.0M in its most recent fiscal year.

What is ATTO EV/EBITDA?

Attovia Therapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 5.90.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Industrials StocksLow P/E Industrials StocksHigh Net Margin Industrials StocksDividend Industrials StocksLow Debt Industrials StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
ATTO Overview ATTO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.